Menu

Magnolia Bark

Also known as: Magnolia officinalis, Hou po, Honokiol, Magnolol

A traditional bark extract marketed for stress and sleep, with most human evidence coming from combination products.

Woodblock-style magnolia blossom, bark chips, and amber extract
Editorial illustration

Magnolia bark extracts contain honokiol and magnolol and are marketed for stress, sleep, and digestive comfort. Human evidence is sparse. A small trial of a magnolia-plus-phellodendron combination cannot show what magnolia alone did, and laboratory calming mechanisms do not establish clinical anxiety or insomnia treatment.2, 1

  • Honokiol and magnolol are major studied constituents1
  • Most clinical evidence uses combination products1
  • Sedation and medicine interactions are plausible1
  • Not established as an anxiety or sleep treatment1

What is Magnolia Bark?

Magnolia officinalis bark has a history of use in East Asian herbal practice. Modern extracts may standardize selected biphenolic compounds, creating an exposure unlike traditional mixed preparations.1

Where it comes from

Natural sources

  • Bark of Magnolia officinalis and related Magnolia species

How it's made

Commercial extracts are solvent-extracted and may be standardized for honokiol and magnolol.

What it does in products

  • Botanical supplement
  • Stress and sleep blend
  • Traditional digestive formula

Benefits

Stress-related symptoms

limited evidence

A small randomized pilot reported changes with a magnolia-and-phellodendron combination.2

Because two botanicals were administered together, the independent contribution of magnolia is unknown.

Sleep or anxiety treatment

insufficient evidence

Human evidence is insufficient to establish magnolia bark as treatment for insomnia or anxiety disorders.1, 2

Mechanistic and animal findings dominate; controlled monotherapy trials are lacking.

Evidence scope and limitations

Oral magnolia bark extracts in adult supplements are covered; traditional multi-herb medical practice is not evaluated as one intervention.

  • Human trials are few and often use proprietary combinations.
  • Constituent standardization varies widely.

Evidence last checked: 2026-09-28

Side effects & safety

Drowsiness, dizziness, or digestive upset (varies)Concentrated extracts and sedative combinations may increase effects.

Safety considerations

  • Avoid during pregnancy and breastfeeding because concentrated-extract safety is not established.
  • Sedatives and sleep medicines
  • Alcohol
  • Anticoagulant or antiplatelet medicines
  • Not for: Driving after a sedating dose
  • Not for: Using it instead of treatment for persistent anxiety or insomnia
2, 3

Amounts studied & product use

These figures describe research or common product use, not a personal dose or treatment recommendation.

In supplement studies and products

The pilot combination trial used a proprietary product rather than a transferable magnolia-only dose; no evidence-based monotherapy range is established.

2

Regulatory status

  • Sold as a dietary supplement; not FDA-approved to treat anxiety, insomnia, or depression.
3

A combination trial cannot validate the solo herb

Brand studies often combine magnolia with phellodendron or other calming ingredients. Even if the blend outperforms placebo, the result cannot be assigned to honokiol, magnolol, or magnolia bark by itself.

2

Frequently asked questions

Does magnolia bark help sleep?

It has plausible sedating activity, but convincing magnolia-only clinical sleep evidence is lacking.2, 1

What is honokiol?

It is one of the major bioactive compounds studied in magnolia bark, not a synonym for every bark extract.2, 1

The bottom line

Magnolia bark has interesting pharmacology, but current human evidence is too sparse and combination-heavy for confident stress or sleep claims.

References

  1. Honokiol: compound summary. PubChem, National Library of Medicine (2026) · ingredient monograph · CID 72303
  2. Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial. Nutrition Journal (2008) · randomized trial · PMID 18426577
  3. Dietary Supplements. U.S. Food and Drug Administration (2025) · government guidance

Revision history

  1. Initial publication with claim-level citations, formulation limits, safety context, and editorial evidence review.